Takeda Pharmaceuticals International AG
Takeda
Takeda is a patient-focused, values-based, RD-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide.
Lobbying Activity
Meeting with Olivér Várhelyi (Commissioner) and
2 Oct 2025 · All pressing portfolio topics
Meeting with Patricia Reilly (Cabinet of President Ursula von der Leyen)
25 Jun 2025 · to follow
Response to Critical Medicines Act
27 Feb 2025
Meeting with Niels Flemming Hansen (Member of the European Parliament)
11 Dec 2024 · Priorites for the mandate
Meeting with Stine Bosse (Member of the European Parliament, Committee chair) and
10 Dec 2024 · European health policy
Meeting with Christian Ehler (Member of the European Parliament)
10 Dec 2024 · Industrial Policy
Meeting with Alexander Bernhuber (Member of the European Parliament)
7 Mar 2024 · Pharma Package
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)
24 Jan 2024 · Directive on Medicinal products for human use
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and
12 Dec 2023 · Directive on Medicinal products for human use
Meeting with Günther Sidl (Member of the European Parliament)
13 Jul 2023 · General Exchange of Views
Meeting with Margrete Auken (Member of the European Parliament, Shadow rapporteur)
7 Jun 2023 · Pharma legislation
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)
7 Jun 2023 · Directive on Medicinal products for human use
Meeting with Salvatore De Meo (Member of the European Parliament)
1 Jun 2023 · SoHO
Meeting with Salvatore De Meo (Member of the European Parliament)
7 Mar 2023 · SoHO
Meeting with Kateřina Konečná (Member of the European Parliament, Shadow rapporteur)
21 Feb 2023 · SOHO regulation
Meeting with Elina Melngaile (Cabinet of Executive Vice-President Valdis Dombrovskis) and Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose
20 Jan 2023 · EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices
Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC
27 Apr 2021
Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products
6 Jan 2021
Meeting with Manuel Mateo Goyet (Cabinet of Commissioner Mariya Gabriel)
14 Sept 2017 · eHealth